Roche Lebanon S.A.R.L. in collaboration with Roche Diagnostics Middle East FZCO (“Roche”) have the pleasure of inviting you to attend the webinar series on SARS-CoV-2 serology testing: Session 5: “Importance of Elecsys Antibody Testing in the context of SARS-CoV-2 Vaccines”
World Health Organization (WHO) has declared the coronavirus outbreak (COVID-19; caused by the virus SARS-CoV-2) as a pandemic. The rapidly increasing demand on health facilities and laboratories threatens to leave some health systems overstretched and unable to operate effectively. The series of webinars help to address those points.
Objectives and Key takeaways:
Highlighting the Role of Ab testing and COVID-19 Vaccine
Enlighten the correlation of Elecsys Anti-SARS CoV-2 S assay with virus-neutralizing capacity – based on latest data and evidence
Emerging evidence on SARS CoV 2 testing in the context of Vaccination
Do you have a question on Antibody testing for COVID-19? Ask the Experts in live Q&A session
Importance of Elecsys Antibody Testing in the context of SARS-CoV-2 Vaccines
Dr. Wim van der Helm, MD
Healthcare Development,
EMEA-LATAM Region Europe,
Middle East, Africa and Latin America
Rotkreuz, Switzerland
Dr. Hans-Joachim Degen
International Product Manager,
Infectious Diseases, Viral Hepatitis and COVID-19
Roche Diagnostics International Ltd
Rotkreuz, Switzerland.
Rabie Elhusseiny
Medical Affairs and
Application Lead Qatar
Roche Diagnostics Middle East
Dr. Anis Yaman
Product Manager – Serum Work Area
Middle East Region
Dubai, UAE
Register now to secure your placeand hear exclusively from the experts on webinar series on SARS-CoV-2 serology testing: Session 5: “Importance of Elecsys Antibody Testing in the context of SARS-CoV-2 Vaccines”
We look forward to welcoming you!
Roche Diagnostics Middle East FZCO
Locally distributed by: Droguerie Omnipharma S.A.L.
Badaro Street – Chaoui Building
P.O. Box 11-7956
Beirut, Lebanon
Join Roche Diagnostics Middle East FCZO for this upcoming webinar on the management of cardiovascular risks of COVID-19 patients.
This webinar will shed light on how cardiac involvement due to acute myocarditis may occur in patients with COVID-19 without respiratory tract signs and symptoms of infection.
You’ll come away with an understanding of:
The potential mechanisms underlying cardiac biomarkers elevation with COVID-19 infections
What biomarkers should be tested and when for the diagnosis of cardiovascular conditions in COVID-19 patients
The value of cardiac biomarkers in COVID-19 patient management
Vous devez être connecté pour poster un commentaire.